Log In
BCIQ
Print this Print this
 

Euflexxa, Nuflexxa, sodium hyaluronate

  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
Description1% non-avian derived sodium hyaluronate
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat pain from osteoarthritis (OA) of the knee; Treat pain in osteoarthritis (OA) patients who failed to respond to nonpharmacologic therapy and simple analgesics
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today